This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Vasopharm Gmbh. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Kirstin Wingler: Innovator in Pharmaceutical Chemistry
Introduction
Kirstin Wingler is a notable inventor based in Würzburg, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific biological processes.
Latest Patents
Kirstin Wingler holds a patent for "Substituted 1,2,3-triazolopyrimidines for the inhibition of NAD(P)H oxidases and platelet activation." This invention relates to compounds of formula het-X-AB, which contain a N-heteroaryl moiety 'het' linked via X=sulfur to the 1,2,3-triazolo[4,5-d]pyrimidine-7-yl moiety AB. The patent also describes a process for preparing these compounds and their use in drugs aimed at treating NAD(P)H oxidase-related diseases and disorders, as well as inhibiting platelet activation.
Career Highlights
Kirstin Wingler is currently associated with Vasopharm GmbH, where she continues her research and development efforts. Her work has been instrumental in advancing therapeutic options for various medical conditions.
Collaborations
Kirstin collaborates with esteemed colleagues, including Frank Tegtmeier and Ulrich Walter, who contribute to her innovative projects and research initiatives.
Conclusion
Kirstin Wingler's contributions to pharmaceutical chemistry and her innovative patent highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile